Oxford Gene Technology (OGT), A Sysmex Group Company, has opened its new facility in Cambridge, UK, in the Cambridge Science Park. The new facility has state-of-the-art refitted laboratories and is approximately three times the size of the company’s previous site. OGT acquired fluorescence in situ hybridisation (FISH) probe manufacturer Cytocell in February 2014. Since then the company has grown its portfolio, including launching the FDA-cleared in vitro diagnostic (IVD) FISH probe range for ...